Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Insights on the Recombinant Proteins Global Market to 2030 - Declining Cost of Therapeutics Recombinant Proteins and Advent of Biosimilars Presents Opportunities

      Research_and_Markets_Logo

      News provided by

      Research and Markets

      Sep 28, 2022, 06:04 ET

      Share this article

      Share this article


      DUBLIN, Sept. 28, 2022 /PRNewswire/ -- The "Recombinant Proteins Market Size, Share & Trends Analysis Report by Host Cell (Insect Cells, Mammalian), by Application (Research, Therapeutics), by Product & Services, by End-user, by Region, and Segment Forecasts, 2022-2030" report has been added to  ResearchAndMarkets.com's offering.

      The global recombinant proteins market size is expected to reach USD 5.09 billion by 2030, registering a CAGR of 12.0% over the forecast period, according to this report.

      Diseases like multiple sclerosis, neutropenia, cerebral apoplexy, anemia, and others, as well as dwarfism, are becoming more common, which is driving up the demand for recombinant protein drugs. Furthermore, the industry is anticipated to expand due to the increased development and research on biologics, which, in turn, are significantly boosting global industry growth. The focus on the development of biosimilars, biologics, and recombinant proteins has increased owing to a rise in the incidence and prevalence of cancer and the expansion of research & development activity.

      According to the American Cancer Society, in 2022, there will be 1.9 million new cases of cancer and 609,360 cancer-related deaths. In addition, the expanding application of recombinant proteins in clinical diagnostic methods including ELISA, Western Blotting, and Immunohistochemistry (IHC) is anticipated to fuel market expansion.

      Due to factors including rising R&D spending, an increase in the number of cancer patients, and the desire for novel & tailored therapies, the global industry is anticipated to expand significantly during the forecast period. Research activity in recombinant protein space has increased in response to the COVID-19 pandemic as a result of efforts to comprehend the dynamics of the virus. The production of recombinant proteins has increased significantly, along with tailored treatment.

      In addition, research funding is predicted to become more readily available along with an increase in demand for and production of recombinant proteins, particularly those immune response proteins associated with COVID-19. Therefore, positive effects have been seen for the companies offering products specifically made for COVID-19.

      Recombinant protein is viewed as a modified version of natural protein that can be produced in a number of ways to improve protein output, create useful commercial goods, and alter gene sequences. The rise in pharmaceutical firms' R&D expenditures, high incidence of chronic illnesses, an increase in the number of regulatory requirements, and the ongoing need to reduce viral infections are the main drivers of the global industry.

      Over the projected period, the global industry is anticipated to be driven by technological advancements in the synthesis of recombinant proteins.

      For instance, in June 2022, according to the data produced by the National Center for Biotechnology Information, new breeding techniques, such as CRISPR/Cas9, TALEN, and Zinc Finger mediated, as well as transgenic or cis-genic techniques, are emerging technologies that may make it easier for in vitro genetic editing or manipulation of the genes to be approved.

      In addition, industry participants are anticipated to invest in the region due to the aging population, rising income levels, better healthcare infrastructure, rising healthcare spending, and the advantages of low-cost manufacturing in developing nations, thereby propelling market growth.

      Recombinant Proteins Market Report Highlights

      • By product & services, the product segment accounted for the largest revenue share in 2021. The demand is increasing globally due to the need for recombinant protein products in biomedical research and increased funding for R&D in the fight against cancer
      • The therapeutics application segment held the maximum revenue share in 2021 due to the prevalence of various diseases, such as metabolic disorders, cancer, genetic disorders, and immune diseases
      • The pharma & biotech companies end-user segment led the global industry in 2021 due to the increasing investments by key market players in their R&D segment to increase research productivity and grow their offerings for revenue generation
      • Mammalian systems are widely used in the production of recombinant proteins, thus, this segment accounted for the largest revenue share in 2021
      • North America was the dominant region in 2021 due to an increase in the incidence of chronic diseases, use of cutting-edge treatments, presence of key players, and rise in healthcare spending in the region
      • Asia Pacific is expected to grow at the fastest CAGR over the projected period due to an uptick in R&D activity, an increase in disposable incomes, and a better understanding of protein therapies among patients
      • India and China are additionally anticipated to see rapid growth in the Asia-Pacific region

      Key Topics Covered:

      Chapter 1 Research Methodology

      Chapter 2 Executive Summary

      Chapter 3 Market Variables, Trends & Scope
      3.1 Market Trends & Outlook
      3.2 Market Segmentation And Scope
      3.3 Market Dynamics
      3.3.1 Market Driver Analysis
      3.3.1.1 Growing Research Activities For Drug Development And Precision Medicine
      3.3.1.2 Rising Adoption Of Biologics And Biosimilars
      3.3.1.3 Increasing Investments In Research & Development Activities
      3.3.2 Market Restraint Analysis
      3.3.2.1 Regulatory And Safety Concerns With Protein Production
      3.3.2.2 Dearth Of Skilled Personnel And Expertise
      3.3.3 Market Opportunity Analysis
      3.3.3.1 Declining Cost Of Therapeutics Recombinant Proteins And Advent Of Biosimilars
      3.3.3.2 Innovative Techniques Can Decrease The Recombinant Protein Production Cost
      3.4 Business Environment Analysis Tools
      3.4.1 Swot Analysis, By Pest
      3.4.2 Porter's Five Forces Analysis
      3.5 Penetration & Growth Prospect Mapping For Product, 2021
      3.6 Recombinant Proteins Market: Covid-19 Impact Analysis

      Chapter 4 Product Segment Analysis
      4.1 Recombinant Proteins Market: Product Movement Analysis
      4.2 Product
      4.2.1 Global Recombinant Proteins Product Market, 2018 - 2030 (USD Million)
      4.2.2 Cytokines &Growth Factors
      4.2.2.1 Global Cytokines & Growth Factors Market, 2018 - 2030 (USD Million)
      4.2.2.1.1 Interferons
      4.2.2.1.1.1 Global Interferons Market, 2018 - 2030 (USD Million)
      4.2.2.1.2 Interleukins
      4.2.2.1.2.1 Global Interleukins Market, 2018 - 2030 (USD Million)
      4.2.2.1.3 Others
      4.2.2.1.3.1 Others Cytokines & Growth Factors Market, 2018 - 2030 (USD Million)
      4.2.3 Antibodies
      4.2.3.1 Global Antibodies Market, 2018 - 2030 (USD Million)
      4.2.4 Immune Checkpoint Proteins
      4.2.4.1 Global Immune Checkpoint Proteins Market, 2018 - 2030 (USD Million)
      4.2.5 Virus Antigens
      4.2.5.1 Global Virus Antigens Market, 2018 - 2030 (USD Million)
      4.2.6 Enzymes
      4.2.6.1 Global Enzymes Market, 2018 - 2030 (USD Million)
      4.2.6.1.1 Kinases
      4.2.6.1.1.1 Global Kinases Market, 2018 - 2030 (USD Million)
      4.2.6.1.2 Metabolic Enzymes
      4.2.6.1.2.1 Global Metabolic Enzymes Market, 2018 - 2030 (USD Million)
      4.2.6.1.3 Others
      4.2.6.1.3.1 Others Enzymes Market, 2018 - 2030 (USD Million)
      4.2.7 Recombinant Regulatory Proteins
      4.2.7.1 Global Recombinant Regulatory Proteins Market, 2018 - 2030 (USD Million)
      4.2.8 Hormones
      4.2.8.1 Global Hormones Market, 2018 - 2030 (USD Million)
      4.2.9 Others
      4.2.9.1 Others Product Market, 2018 - 2030 (USD Million)
      4.3 Production Services
      4.3.1 Global Recombinant Proteins Production Services Market, 2018 - 2030 (USD Million)

      Chapter 5 Application Segment Analysis
      5.1 Recombinant Proteins Market: Application Movement Analysis
      5.2 Drug Discovery & Development
      5.2.1 Global Drug Discovery & Development, 2018 - 2030 (USD Million)
      5.3 Therapeutics
      5.3.1 Global Therapeutics Market, 2018 - 2030 (USD Million)
      5.3.2 Biologics
      5.3.2.1 Global Biologics Market, 2018 - 2030 (USD Million)
      5.3.3 Vaccines
      5.3.3.1 Global Vaccines Market, 2018 - 2030 (USD Million)
      5.3.4 Cell & Gene Therapies
      5.3.4.1 Global Cell & Gene Therapies Market, 2018 - 2030 (USD Million)
      5.3.5 Others
      5.3.5.1 Others Therapeutics Market, 2018 - 2030 (USD Million)
      5.4 Research
      5.4.1 Global Research Market, 2018 - 2030 (USD Million)
      5.5 Other
      5.5.1 Other Application Market, 2018 - 2030 (USD Million)

      Chapter 6 End-User Segment Analysis
      6.1 Recombinant Proteins Market: End-User Movement Analysis
      6.2 Pharmaceutical & Biotechnology Companies
      6.2.1 Global Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
      6.3 Academic & Research Institutes
      6.3.1 Global Academic & Research Institutes Market, 2018 - 2030 (USD Million)
      6.4 Diagnostic Laboratories
      6.4.1 Global Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
      6.5 Others
      6.5.1 Other End-Users, 2018 - 2030 (USD Million)

      Chapter 7 Host-Cells Segment Analysis
      7.1 Recombinant Proteins Market: Host-Cells Movement Analysis
      7.2 Mammalian Systems
      7.2.1 Global Mammalian Systems Market, 2018 - 2030 (USD Million)
      7.3 Insects Cells
      7.3.1 Global Insects Cells Market, 2018 - 2030 (USD Million)
      7.4 Yeast & Fungi
      7.4.1 Global Yeast & Fungi Market, 2018 - 2030 (USD Million)
      7.5 Bacterial Cells
      7.5.1 Global Bacterial Cells Market, 2018 - 2030 (USD Million)
      7.6 Others
      7.6.1 Other Host-Cells, 2018 - 2030 (USD Million)

      Chapter 8 Regional Outlook

      Chapter 9 Competitive Landscape
      9.1 Strategy Framework
      9.2 Market Participation Categorization
      9.3 Company Profiles
      9.3.1 Thermo Fisher Scientific, Inc.
      9.3.1.1 Company Overview
      9.3.1.2 Financial Performance
      9.3.1.3 Product Benchmarking
      9.3.1.4 Strategic Initiatives
      9.3.2 Abcam plc
      9.3.2.1 Company Overview
      9.3.2.2 Financial Performance
      9.3.2.3 Product/Service Benchmarking
      9.3.2.4 Strategic Initiatives
      9.3.3 Bio-Rad Laboratories, Inc.
      9.3.3.1 Company Overview
      9.3.3.2 Financial Performance
      9.3.3.3 Product/Service Benchmarking
      9.3.3.4 Strategic Initiatives
      9.3.4 Bio-Techne Corporation
      9.3.4.1 Company Overview
      9.3.4.1.1 R&D Systems
      9.3.4.2 Financial Performance
      9.3.4.3 Product Benchmarking
      9.3.4.4 Strategic Initiatives
      9.3.5 Merck KGaA
      9.3.5.1 Company Overview
      9.3.5.2 Financial Performance
      9.3.5.3 Product Benchmarking
      9.3.5.4 Strategic Initiatives
      9.3.6 GenScript Biotech Corporation
      9.3.6.1 Company Overview
      9.3.6.2 Financial Performance
      9.3.6.3 Product Benchmarking
      9.3.6.4 Strategic Initiatives
      9.3.7 RayBiotech Life, Inc.
      9.3.7.1 Company Overview
      9.3.7.2 Financial Performance
      9.3.7.3 Product Benchmarking
      9.3.7.4 Strategic Initiatives
      9.3.8 Proteintech Group, Inc.
      9.3.8.1 Company Overview
      9.3.8.2 Financial Performance
      9.3.8.3 Product Benchmarking
      9.3.8.4 Strategic Initiatives
      9.3.9 Enzo Life Sciences, Inc.
      9.3.9.1 Company Overview
      9.3.9.2 Financial Performance
      9.3.9.3 Product Benchmarking
      9.3.9.4 Strategic Initiatives
      9.3.10 STEMCELL Technologies Inc
      9.3.10.1 Company Overview
      9.3.10.2 Financial Performance
      9.3.10.3 Product Benchmarking
      9.3.10.4 Strategic Initiatives
      9.3.11 Sino Biological, Inc.
      9.3.11.1 Company Overview
      9.3.11.2 Financial Performance
      9.3.11.3 Product Benchmarking
      9.3.11.4 Strategic Initiatives
      9.3.12 Abnova Corporation
      9.3.12.1 Company Overview
      9.3.12.2 Financial Performance
      9.3.12.3 Product Benchmarking
      9.3.12.4 Strategic Initiatives

      For more information about this report visit https://www.researchandmarkets.com/r/414ivj

      Media Contact:

      Research and Markets
      Laura Wood, Senior Manager
      [email protected]

      For E.S.T Office Hours Call +1-917-300-0470
      For U.S./CAN Toll Free Call +1-800-526-8630
      For GMT Office Hours Call +353-1-416-8900

      U.S. Fax: 646-607-1907
      Fax (outside U.S.): +353-1-481-1716

      Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

      SOURCE Research and Markets

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.